Boiron SA (BOI) Company Profile - CorporateInformation.com


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Boiron SA Company Snapshot

Business Description:

Boiron SA operates in the Pharmaceutical preparations sector. Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and proprietary drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA has operations in 60 countries through 18 subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others. In our complete report available for purchase the company is compared to: Ipsen, Vetoquinol Sa and Hikma Pharmaceuticals PLC.

Boiron SA

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 22.28
(Figures in Euro)

1 Week	2.8%	13 Weeks	-0.4%

4 Weeks	10.8%	52 Weeks	-21.7%

Boiron SA Key Data:

Ticker:	BOI	Country:	FRANCE

Exchanges:	PAR	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2011 Sales	523,215,000 (Year Ending Jan 2012).	Employees:	4,081

Currency:	Euro	Market Cap:	478,413,917

Fiscal Yr Ends:	December	Shares Outstanding:	21,472,797

Share Type:	Actions Ordinaries	Closely Held Shares:	15,109,003

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.